Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
CRISPR Craze to Transform Cardiac Biology: Trends in Molecular Medicine
5 Big Mysteries about CRISPR's Origins - Scientific American
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome.,Nature Medicine - X-MOL
What's new in clinical CRISPR? | Nature Medicine
Nature Medicine重磅文章：新型CRISPR-Cas9技术能够实现完整内源性基因的替换，成功治疗β-地贫小鼠模型-上海玮驰仪器有限公司
The Heroes of CRISPR: Cell
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
CRISPR algorithm predicts how well gene editing will work - Scope
CRISPR: Gene editing and beyond - YouTube
PDF) Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Cornerstones of CRISPR–Cas in drug discovery and therapy | Nature Reviews Drug Discovery
First CRISPR editing trial results assuage safety concerns
Cornerstones of CRISPR–Cas in drug discovery and therapy | Nature Reviews Drug Discovery
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
Highly efficient therapeutic gene editing of human hematopoietic stem cells | Nature Medicine
Frontiers | CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future | Oncology
三篇Nature Medicine聚焦AAV-CRISPR基因治疗的长期疗效和安全性- X-MOL资讯
CRISPR–Cas: a tool for cancer research and therapeutics | Nature Reviews Clinical Oncology
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
How CRISPR Is Changing Cancer Research and Treatment - National Cancer Institute
Controlling and enhancing CRISPR systems | Nature Chemical Biology
